What is Kura Oncology's net investment in lease?

Kura Oncology (KURA) reported net investment in lease of $7.17M in Q1 2026.

How has Kura Oncology's net investment in lease changed year-over-year?

Kura Oncology's net investment in lease decreased by 12.0% year-over-year, from $8.14M to $7.17M.

What is the long-term trend for Kura Oncology's net investment in lease?

Over 5 years (2020 to 2025), Kura Oncology's net investment in lease has grown at a 2.9% compound annual growth rate (CAGR), from $6.33M to $7.3M.

Kura Oncology KURA Net Investment in Lease

Net Investment in Lease at other companies

Syndax PharmaceuticalsSNDX

——

Corvus PharmaceuticalsCRVS

——

Nuvation BioNUVB

——

Cullinan Therapeutics, Inc.CGEM

——

SELLAS Life Sciences Group, Inc.SLS

——

Bicara TherapeuticsBCAX

——

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's net investment in lease?: Kura Oncology (KURA) reported net investment in lease of $7.17M in Q1 2026.
How has Kura Oncology's net investment in lease changed year-over-year?: Kura Oncology's net investment in lease decreased by 12.0% year-over-year, from $8.14M to $7.17M.
What is the long-term trend for Kura Oncology's net investment in lease?: Over 5 years (2020 to 2025), Kura Oncology's net investment in lease has grown at a 2.9% compound annual growth rate (CAGR), from $6.33M to $7.3M.